Native Roots Hemp Warning Letter Details

Summary

Based on limited metadata, Native Roots Hemp received an FDA Warning Letter on April 6, 2020, regarding drug products. Without access to the full letter text or detailed subject line information, the specific nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, suggesting the company's hemp-derived products were being treated as unapproved drugs or were in violation of drug manufacturing, labeling, or marketing requirements. Additional details about the specific violations would require review of the complete Warning Letter document.